Varani K, Cacciari B, Baraldi P G, Dionisotti S, Ongini E, Borea P A
Dipartimento di Medicina Clinica e Sperimentale-Sezione di Farmacologia, Università degli Studi di Ferrara, Italy.
Life Sci. 1998;63(5):PL 81-7. doi: 10.1016/s0024-3205(98)00289-6.
The A3 adenosine receptor is one of the four adenosine receptors which have thus far been identified. Cloning of the A3 receptor from animal species such as rat, sheep and human has shown that there are interspecies differences in its peripheral distribution, and binding affinity for various adenosine receptor ligands. The adenosine derivative, 4-aminobenzyl-5'-N-methylcarboxamidoadenosine (AB-MECA), is a potent A3 receptor agonist which is used as a reference drug. In this report we have characterized the binding of selected adenosine receptor agonists and antagonists to HEK 293 cells transfected with the human A3 adenosine receptor using [125I]AB-MECA as radioligand. HE-NECA and NECA were the most potent compounds showing Ki values in the low nanomolar range, while the recently discovered non-xanthine A2A receptor antagonists ZM 241385, SCH 58261 and SCH 63390 showed affinity values in the micromolar range. These data further indicate the need to examine the affinity of new adenosine receptor ligands directly in human A3 receptors.
A3腺苷受体是目前已确定的四种腺苷受体之一。从大鼠、绵羊和人类等动物物种中克隆A3受体表明,其外周分布以及对各种腺苷受体配体的结合亲和力存在种间差异。腺苷衍生物4-氨基苄基-5'-N-甲基羧酰胺腺苷(AB-MECA)是一种强效A3受体激动剂,用作参考药物。在本报告中,我们使用[125I]AB-MECA作为放射性配体,对选定的腺苷受体激动剂和拮抗剂与人A3腺苷受体转染的HEK 293细胞的结合进行了表征。HE-NECA和NECA是最有效的化合物,其Ki值在低纳摩尔范围内,而最近发现的非黄嘌呤A2A受体拮抗剂ZM 241385、SCH 58261和SCH 63390的亲和力值在微摩尔范围内。这些数据进一步表明有必要直接在人A3受体中检测新的腺苷受体配体的亲和力。